The safety and efficacy of sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer

被引：3
|
作者：
Powles, T.
Kayani, I.
Blank, C. U.
Chowdhury, S.
Horenblas, S.
Sarwar, N.
Nathan, P. D.
Boleti, E.
Haanen, J. B.
Bex, A.
机构：
[1] Barts & London Queen Marys Sch Med & Dent, London, England
[2] UCH, London, England
[3] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[4] Guys & St Thomas Hosp, London SE1 9RT, England
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] St Bartholomews Hosp, London, England
[7] Mt Vernon Canc Ctr, Northwood, Middx, England
[8] Royal Free Hosp, London NW3 2QG, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4603
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma
    Zhu, Xudong
    Zhang, Xingming
    Sun, Guangxi
    Liu, Zhenhua
    Zhang, Haoran
    Yang, Yaojing
    Ni, Yuchao
    Dai, Jindong
    Zhu, Sha
    Chen, Junru
    Zhao, Jinge
    Wang, Zhipeng
    Zeng, Hao
    Shen, Pengfei
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6833 - 6845
  • [42] A pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (mRCC)
    Hutson, T. E.
    Bukowski, R.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    BJU INTERNATIONAL, 2012, 109 : 5 - 6
  • [43] To compare the efficacy and safety of pazopanib and sunitinib in metastatic renal cell carcinoma (RCC) of Chinese population
    Chan, M. F. T.
    Lam, Q. Y. N.
    Lee, V. H. F.
    Siu, S. W. K.
    Kwong, P. W. K.
    Leung, T. W.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [44] Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
    Staehler, Michael
    Battle, Dena
    Bex, Axel
    Hammers, Hans
    George, Daniel
    EUROPEAN UROLOGY, 2018, 74 (06) : 842 - 843
  • [45] Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma
    Flanigan, Robert C.
    EUROPEAN UROLOGY, 2019, 75 (05) : 876 - 877
  • [46] Nephrectomy for metastatic renal-cell cancer
    Schwartz, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (14): : 1095 - 1095
  • [47] New biomarkers of sunitinib efficacy in metastatic renal cell carcinoma
    Bolzacchini, E.
    Dentali, F.
    Tartaro, T.
    Tuzi, A.
    Proserpio, I.
    Pinotti, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 66 - 66
  • [48] Sunitinib and everolimus for the treatment of a patient with clear cell renal cancer
    Bodnar, Lubomir
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C7 - C8
  • [49] Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
    Kayani, Irfan
    Avril, Norbert
    Bomanji, Jamshed
    Chowdhury, Simon
    Rockall, Andrea
    Sahdev, Anju
    Nathan, Paul
    Wilson, Peter
    Shamash, Jonathan
    Sharpe, Kevin
    Lim, Louise
    Dickson, John
    Ell, Peter
    Reynolds, Andrew
    Powles, Thomas
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 6021 - 6028
  • [50] VEGF Expression and Response to Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Minardi, Daniele
    Lucarini, Guendalina
    Santoni, Matteo
    Mazzucchelli, Roberta
    Burattini, Luciano
    Pistelli, Mirco
    Bianconi, Maristella
    Di Primio, Roberto
    Scartozzi, Mario
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2013, 33 (11) : 5017 - 5022
12345